Literature DB >> 11354365

Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles.

P Schumann1, V Collot, Y Hommet, W Gsell, F Dauphin, J Sopkova, E T MacKenzie, D Duval, M Boulouard, S Rault.   

Abstract

The synthesis and pharmacological evaluation of methoxyindazoles as new inhibitors of neuronal nitric oxide synthase are presented. The 7-methoxyindazole, although less potent than 7-NI, is the most active compound of the series in an in vitro enzymatic assay of neuronal nitric oxide synthase activity. This result shows that the nitro-substitution is not indispensable to the biological activity of the indazole ring. 7-Methoxyindazole possesses in vivo NOS inhibitory as well and related antinociceptive properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354365     DOI: 10.1016/s0960-894x(01)00156-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

2.  A novel indazolo-triazolo-benzotriazepine exerts anti-inflammatory effects by inhibition of cyclooxygenase-2 activity and nitric oxide synthase-2 expression.

Authors:  Patricia Fernández; M Isabel Guillén; Amalia Ubeda; Pablo López-Cremades; Enrique Aller; Angeles Lorenzo; Pedro Molina; M José Alcaraz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-06-24       Impact factor: 3.000

3.  Toward biophysical probes for the 5-HT3 receptor: structure-activity relationship study of granisetron derivatives.

Authors:  Sanjeev Kumar V Vernekar; Hasan Y Hallaq; Guy Clarkson; Andrew J Thompson; Linda Silvestri; Sarah C R Lummis; Martin Lochner
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.